2019
DOI: 10.1093/cid/ciz670
|View full text |Cite
|
Sign up to set email alerts
|

Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55–70 Study

Abstract: Background There are limited data on the comparative prevalence of neurocognitive impairment (NCI) in aging people living with human immunodeficiency virus (PLHIV) and people not living with HIV. Methods This was a cross-sectional study of PLHIV randomly matched by age (±4 years), gender, and education with 5 HIV-uninfected individuals from the CONSTANCES cohort. PLHIV were fluent in French and sequentially included during ro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 40 publications
0
18
0
Order By: Relevance
“…The availability of combination antiretroviral therapy (cART) has greatly improved life expectancy among persons with HIV (PWH) who have access to adequate health care (Samji et al, 2013). Despite the beneficial effects of cART on controlling HIV viremia, neurocognitive impairment remains prevalent among PWH, particularly in PWH aged 50 and older (Cherner et al, 2004;Makinson et al, 2019). However, recent studies demonstrate that some PWH are able to achieve successful cognitive aging (i.e., generally defined as preserved cogntion and everyday functioning; Malaspina et al, 2011;Moore et al, 2014Moore et al, , 2018.…”
Section: Introductionmentioning
confidence: 99%
“…The availability of combination antiretroviral therapy (cART) has greatly improved life expectancy among persons with HIV (PWH) who have access to adequate health care (Samji et al, 2013). Despite the beneficial effects of cART on controlling HIV viremia, neurocognitive impairment remains prevalent among PWH, particularly in PWH aged 50 and older (Cherner et al, 2004;Makinson et al, 2019). However, recent studies demonstrate that some PWH are able to achieve successful cognitive aging (i.e., generally defined as preserved cogntion and everyday functioning; Malaspina et al, 2011;Moore et al, 2014Moore et al, , 2018.…”
Section: Introductionmentioning
confidence: 99%
“…This study serves as an example of how understanding the dynamic relationships between daily life activities and cognition could lead to improved symptoms or disease tracking or just-in-time adaptive interventions to promote optimal neurocognitive functioning, when desired, using digital health technologies. Such interventions may be important for older adults [ 25 ] and persons with HIV [ 26 , 27 ], particularly older persons with HIV, given the higher rates of neurocognitive impairment compared with the general population.…”
Section: Introductionmentioning
confidence: 99%
“…Approximately 15-50% of people living with HIV (PLWH) show HIV-associated neurocognitive disorder (HAND) (Schouten et al, 2011). The prevalence varies according to the population studied and increases with age (Makinson et al, 2019). Methods used to define impairment also have an impact on the prevalence (Underwood et al, 2019).…”
Section: Introductionmentioning
confidence: 99%